(Q85644770)
Statements
Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide (English)
Salvatore Luca Burgio
Cecilia Menna
Elisa Carretta
Lorena Rossi
Emanuela Bianchi
Carla Masini
27 September 2014